Med BioGene Gets Additional Investment from SEP Capital

The firm will sell nearly C$500,000 (US$434,000) in units to the investment firm in a private placement.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.